Carbamazepine

Product NDC
70518-4492
11-digit product format
705184492
Labeler code
70518
Product ID
70518-4492_407d64af-d3f0-7235-e063-6394a90ac39f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carbamazepine
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA078986
Marketing category
ANDA
Marketing start
2025-10-06
Substance
CARBAMAZEPINE
Active strength
300 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
33CM23913MCARBAMAZEPINE298-46-4CARBAMAZEPINE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-4492-07051844920030 POUCH in 1 BOX (70518-4492-0) / 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-4492-1) 30 pouch2025-10-06NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Carbamazepine Extended-Release Capsules 100 mg, 200 mg and 300 mg Rx onlyREMEDYREPACK INC.2025-10-06HUMAN PRESCRIPTION DRUG LABEL1